Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease

Venkateswaran N, Bian Y, Gupta PK

Clinical Ophthalmology 2022, 16:349-355

Published Date: 9 February 2022